Investor.sagerx.com

Sage Therapeutics to Present at the 42nd Annual J.P.

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 2, 2024-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world …

Actived: 1 days ago

URL: https://investor.sagerx.com/news-releases/news-release-details/sage-therapeutics-present-42nd-annual-jp-morgan-healthcare

Sage Therapeutics and Biogen Announce Positive, One …

WebIn the zuranolone 50 mg cohort, the majority of patients who responded to an initial 14-day course received only one two-week course of treatment during the study …

Category: Course Go Health

FDA Approves ZURZUVAE™ (zuranolone), the First and …

WebPostpartum depression (PPD) approval based on results from two Phase 3 clinical trials; in the SKYLARK Study treatment with ZURZUVAE rapidly improved …

Category: Health Go Health

Sage Therapeutics to Provide Business Updates at 42nd …

WebExcitement over December 2023 launch of ZURZUVAE™ (zuranolone), the first and only oral treatment indicated for adults with postpartum depression (PPD). …

Category: Health Go Health

Sage Therapeutics Implements Strategic Reorganization …

WebPotential growth catalysts include planned 4Q 2023 launch of ZURZUVAE (zuranolone) and expected data read-outs for SAGE-718 and SAGE-324 in 2024

Category: Health Go Health

Sage Therapeutics to Present at Upcoming August …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 1, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world …

Category: Health Go Health

Sage Therapeutics and Biogen Announce FDA Accepts …

WebZuranolone is being evaluated as a potential 14-day, rapid-acting, once-daily, oral medication to treat major depressive disorder (MDD) and postpartum depression (PPD)

Category: Health Go Health

Sage Therapeutics Announces FDA Approval of …

WebThe Investor Relations website contains information about Sage Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

Category: Health Go Health

Sage Therapeutics to Participate in Upcoming May Investor …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--May 7, 2024-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world …

Category: Health Go Health

Sage Therapeutics to Present at Bernstein’s 34th Annual …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--May 23, 2018-- Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing …

Category: Health Go Health

Sage Therapeutics Announces Continued Positive Zuranolone …

WebIn the now completed 30 mg zuranolone cohort, approximately 70% of participants with positive response to an initial 2-week treatment required at most one …

Category: Health Go Health

Sage Therapeutics to Present at J.P. Morgan Healthcare …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 23, 2019-- Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company committed to developing …

Category: Health Go Health

Sage Therapeutics Appoints Laura M. Gault, M.D., Ph.D. as Chief …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov. 1, 2022-- Sage Therapeutics (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with …

Category: Health Go Health

Sage Therapeutics to Present at the 2016 Leerink Global …

WebThe Investor Relations website contains information about Sage Therapeutics, Inc.'s business for stockholders, potential investors, and financial analysts.

Category: Health Go Health

Sage Therapeutics to Present at Morgan Stanley 20th Annual …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 2, 2022-- Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world …

Category: Health Go Health

Sage Therapeutics Announces Third Quarter 2022 Financial Results …

WebCompletion of rolling NDA submission for zuranolone in MDD and PPD on track for December 2022. Presented additional data across pipeline programs at key …

Category: Health Go Health

42nd Annual J.P. Morgan Healthcare Conference

Web42nd Annual J.P. Morgan Healthcare Conference. Jan 8, 2024 4:30 PM PST. Listen to webcast.

Category: Health Go Health

Sage Therapeutics to Present at Upcoming September Investor …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 6, 2023-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world …

Category: Health Go Health

Sage Therapeutics to Present at the Goldman Sachs 44th Annual …

WebCAMBRIDGE, Mass.--(BUSINESS WIRE)--Jun. 5, 2023-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world …

Category: Health Go Health

ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for …

WebZURZUVAE, the first and only oral, once-daily, 14-day treatment course, has shown to provide rapid improvements in depressive symptoms at Day 15 and as early as …

Category: Course Go Health

Sage Therapeutics Announces Positive Interim, Topline …

WebZuranolone was generally well-tolerated at the 30 mg dose and by the initial patients treated with the 50 mg dose with an adverse event profile consistent with that …

Category: Health Go Health

Top Categories

› Appendicitis

› Gout

› Women's Health

› Thyroid

› Sleep

› Skin

› Sexual Health

› Senior Health

› Oral Health

› Mental Health

› Men's Health

› Medications

› Lung Conditions

› Infectious Disease

Popular Searched

› Zocdoc lasante health center

› Tracy carter summa health

› Capital health regional medical center in trenton

› Msowprod trinity health org

› Is bean dip healthy

› Healthy eating week uk 2024

› Spain health workers protest

› Virginia premier health plan cost

› 21 days mental health challenge

› Health assistance program uvm

Recently Searched

› Great barrington health center ma

› Adventist health castle bistro menu

› Horizon health edgar county

› Mercy health labs muskegon

› Tennessee health disparity team

› Iu health sleep apnea center

› Health care with pre existing conditions

› Public health funeral services uk

› Horizon health care practice derby

› Oak street health age requirements

The medical information found on the MedMallRx website is designed to support, not to replace the relationship between patient and physician and the medical advice they may provide.